Anabolic Steroids and High Hematocrit: Blood Counts, Symptoms and Care

How anabolic steroids affect hematocrit, what blood counts can show, when clot symptoms need care and why high results need medical assessment.

On this page

Anabolic steroids can increase red blood cell production and raise hematocrit. A high result needs medical assessment, but it does not diagnose a blood clot. Symptoms, repeat blood counts, other causes and the exact androgen exposure all shape the next step. A normal result cannot rule out a clot when symptoms suggest one.

New pain and swelling in one leg need urgent medical assessment. If these symptoms come with chest pain or breathlessness, call emergency services. Do not wait for another blood test.

What hematocrit, hemoglobin and red cell counts show

Hematocrit, often written Hct, is the proportion of blood occupied by red blood cells. A result of 0.52 L/L means 52%; these are two ways of expressing the same measurement. This example explains the units, not a target or a safe boundary. Interpret the result against the laboratory range and your previous results. Age, sex, altitude and fluid balance can affect its meaning. MedlinePlus hematocrit information

A complete blood count (CBC), also called a full blood count, includes several separate measurements. Hemoglobin (Hb) is the oxygen carrying protein in red cells. The red blood cell (RBC) count measures their number, while mean cell volume describes their average size. Platelets and white cells are other components of the count. These measurements help clinicians interpret a pattern; they are not interchangeable. MedlinePlus blood count information

Blood count findings during anabolic steroid or testosterone exposure
FindingWhat it can showWhat it cannot establish
Raised hematocrit during anabolic steroid useA larger proportion of the sample consists of red cells.The result alone does not identify the cause.
Raised hemoglobin during testosterone exposureMore hemoglobin is measured in the blood sample.This is not a diagnosis of a vein clot.
Raised red cell countThe number of red cells is above the laboratory range.Cell number alone does not describe cell size or the whole blood count.
A count inside the laboratory rangeThe measured count falls within that reference interval.Symptoms suggesting a clot still need their own assessment.

This page covers blood counts and clot concerns. The broader anabolic steroid side effects page connects this issue with other organ effects, while blood tests during anabolic steroid exposure covers the wider testing picture.

How anabolic steroids affect red blood cells

Testosterone can initially increase erythropoietin (EPO), a hormone signal that encourages red cell production. It can also suppress hepcidin, a hormone that limits iron absorption. Lower hepcidin makes more iron available to support production of red cells. These mechanisms help explain the blood count response; they do not predict the size of an individual increase. Hormone and iron mechanisms reviewed in 2024

Testosterone can stimulate red cell production. The response varies with exposure and the person receiving it; prescribed treatment can cause erythrocytosis too. A 2025 systematic review found wide variation across studies of medicine related erythrocytosis. Among testosterone studies, injections, higher doses and older age were associated with greater occurrence. The review does not establish a reliable percentage for every nonmedical steroid combination or a product ranking for safe use. 2025 review of medicine related erythrocytosis

In a prospective study of 100 men using anabolic steroids, mean hematocrit increased by 0.03 L/L during exposure, equivalent to three percentage points. Blood pressure and lipid measurements also changed. Group measurements returned to baseline at followup three months after the cycle and one year after its start. This was an observational study with limited followup, not proof that each person recovered on that schedule or avoided later cardiovascular harm. Prospective study of 100 anabolic steroid users

Why a high result has more than one possible cause

Erythrocytosis means an increased red cell concentration. Relative erythrocytosis can occur when the liquid part of blood is reduced, as with dehydration, without a matching increase in red cell mass. Absolute erythrocytosis involves increased red cell mass. It may be secondary to another stimulus or arise from a marrow disorder. Polycythemia vera is a specific blood cancer and is not another name for every high hematocrit result. NHS erythrocytosis information

Smoking and carbon monoxide exposure, sleep apnea, lung disease, altitude and some kidney conditions can contribute. More than one cause can coexist with androgen use. A normal oxygen reading in the clinic does not exclude sleep apnea or carbon monoxide related problems. Naming steroids as one exposure should not end the investigation of a persistent abnormal count. Clinical review of erythrocytosis assessment

Other medicines can be relevant too, including some sodium glucose cotransporter 2 (SGLT2) inhibitors used for diabetes, heart failure or kidney disease. Bring the full medicine list to the review. Do not stop a prescribed medicine independently because it appears on a list of possible causes. The clinical decision depends on the indication, result and competing risks. Medicine exposures assessed in the 2025 review

Does high hematocrit mean a blood clot will happen?

No single hematocrit result predicts that outcome. A raised red cell concentration can increase blood viscosity, but clot formation has several contributors. The evidence linking a laboratory change with later events must be read separately from the evidence that androgens can raise the count.

A 2022 retrospective study matched 5,842 men with low testosterone receiving testosterone treatment who developed hematocrit of at least 52% with 5,842 who did not. The combined outcome of major cardiovascular events or venous clots occurred in 5.15% versus 3.87% during the first year. This was an association from medical records. The result combines different events, does not measure clot risk alone and cannot show that hematocrit caused every event. These percentages are not a personal forecast for someone using nonmedical anabolic steroids. Matched testosterone treatment cohort

A suspected DVT, a type of vein clot, requires clinical assessment and may require ultrasound. A CBC is not the test that locates it. Recent surgery, immobility, a previous clot or cancer can alter the clinical picture, so report them even if your blood count was normal. NHS vein clot assessment

What prescribed testosterone thresholds mean

The Endocrine Society recommends checking hematocrit before prescribed testosterone, again after three to six months and then annually. Its recommendation for a result above 54% is for the treating clinician to stop therapy until the count is acceptable, investigate low oxygen and sleep apnea, and consider restarting at a reduced dose. This is a medical treatment decision, not a home adjustment protocol. Endocrine Society testosterone recommendations

Product instructions can differ. The current XYOSTED testosterone label calls for hematocrit checks approximately every three months and interruption for an elevated result. It also gives instructions for recurrent elevation after restarting. Your prescriber should use the instructions relevant to the product and your clinical circumstances. XYOSTED prescribing information

The study definition of 52%, a treatment recommendation above 54% and a laboratory reference interval answer different questions. None creates a guaranteed safe zone for nonmedical exposure. A result below those numbers does not cancel clot symptoms. If your report is flagged, rises substantially or reaches a threshold your clinician has set, contact the clinician responsible for the test and obtain a clear plan.

What medical assessment may involve

A clinician may repeat the CBC and review its hemoglobin, hematocrit, cell size, platelet and white cell pattern. Ferritin, kidney and liver tests can help investigate associated findings. Depending on the history, assessment may include oxygen measurements, sleep testing, erythropoietin testing or JAK2 testing for a marrow cause. Imaging and hematology referral are selected for the clinical picture, rather than ordered automatically for every steroid user. Tests used to investigate persistent erythrocytosis

Bring dated results with units and laboratory ranges. Tell the clinician about recent illness, fluid loss, altitude, smoking, snoring or interrupted breathing during sleep. Do not try to make a result look lower through unusual fluid intake or by arranging blood removal before the assessment. Follow the laboratory instructions; a CBC alone usually needs no special preparation, although other tests collected at the same visit may. Preparing for a blood count

The plan should identify who reviews the repeat result, how soon it is needed and which symptoms should change the timing. A falling count is useful information, but it does not explain an unresolved abnormality or replace an assessment for a suspected clot.

Why donation and blood thinning medicines are not a home fix

Therapeutic phlebotomy means medically directed blood removal. Its role depends on the diagnosis. Treatment used for polycythemia vera cannot simply be transferred to androgen related erythrocytosis; routine phlebotomy is not recommended for every secondary cause. Cause specific treatment of erythrocytosis

A 2024 review found that evidence for the safety and benefit of phlebotomy in testosterone associated erythrocytosis is limited. Repeated removal can deplete iron stores. That uncertainty supports a clinician led decision about the cause and treatment, rather than a repeating donation schedule to permit continued exposure. It does not establish that all medically prescribed phlebotomy is harmful. 2024 review of phlebotomy during testosterone treatment

Do not start aspirin to manage a high count. Aspirin can cause bleeding and stomach ulcers, and its use should match a clinical indication. If it is already prescribed, ask the prescriber before changing it. NHS aspirin information Anticoagulants also carry bleeding risks and require the correct indication and supervision. They are not a substitute for investigating an abnormal blood count. NHS anticoagulant safety information

Testosterone can change the response to warfarin, so its prescribing information calls for closer clotting test monitoring when androgen therapy starts or stops. Tell the anticoagulation service about every androgen product and any change in exposure. Corticosteroids and other medicines should also be disclosed because interactions and fluid retention may affect the wider assessment. Testosterone medicine interactions

When symptoms need attention

What recovery and followup can tell you

The prospective anabolic steroid study showed that group blood counts could return to baseline after exposure ended. It did not provide an individual deadline for recovery or demonstrate that a normal count erased earlier harm. Continued elevation deserves a review of ongoing exposure and other possible causes. Followup findings in the prospective study

The prospective HAARLEM study followed 100 men with measurements before and during androgen exposure, three months after the cycle and one year after its start. Average hematocrit rose during use and returned to baseline at the reported followup visits. The study’s followup was limited to one year. These group measurements are not a deadline for an individual count to normalize and do not show that clot risk or other cardiovascular harm has disappeared.

Keep followup focused on both the count and the person: symptoms, the agreed treatment decision and the reason for any remaining abnormality. Blood pressure and other cardiovascular findings belong in the wider review. Correcting one laboratory measurement does not answer every question about the effects of anabolic steroids.

What to take to the appointment

  • All blood count reports, with dates, units and reference ranges.
  • The names or photographs of androgen products, dose history, route and last use, including prescribed testosterone.
  • Other medicines and supplements, including aspirin, anticoagulants and any previous blood donation or therapeutic blood removal.
  • A short timeline of symptoms, past clots, recent operations or immobility, smoking and sleep concerns.
  • Your questions about the suspected cause, repeat testing, referral and who will contact you with the result.

For acute symptoms, use the care advice above. For a stable abnormal result, arrange a review that ends with a named followup plan rather than treating the number on its own.